Quirogane, Prenopsane, and Patzcuarane Skeletons
J ournal of Natural Products, 2002, Vol. 65, No. 10 1409
-37°, [R]546 -43°, [R]436 -83°, [R]365 low energy (c 0.16, CHCl3);
UV (EtOH) λmax (log ꢀ) 212 (3.63), 259 (4.10) nm; IR (CHCl3)
νmax 3616, 3468 (OH), 1716 (CdO benzoate), 1608 (CdC
aromatic), 1530, 1280 (NO2) cm-1; 1H NMR (CDCl3, 300 MHz),
see Table 3 and δ 8.26 and 8.17 (4H, AA′BB′, H-4′,6′ and H-3′,7′
p-nitrobenzoate), 2.48 (2H, br s, OH); 13C NMR (CDCl3, 75.4
MHz), see Table 4 and δ 164.1 (CdO benzoate), 150.4 (C-5′),
136.1 (C-2′), 130.6 (C-3′ and C-7′), 123.4 (C-4′ and C-6′); EIMS
m/z 385 [M - (H2O)]+ (0.2), 373 (0.6), 260 (9), 236 (7), 218 (19),
203 (18), 175 (53), 150 (77), 121 (58), 107 (48), 95 (100), 81
(21), 69 (27), 55 (11), 43 (2); HRDCIMS (NH3) m/z 421.2320
(calcd for C22H29O6N + NH4+, 421.2339).
23%). Fractions eluting with EtOAc afforded 15 (12.5 mg, 3%),
and fractions eluting with MeOH/EtOAc (1:19) gave 10 (7.3
mg, 2%). Subsequent separation of the mixture by flash
chromatography on silica gel using acetone/EtOAc/CH2Cl2 (1:
6:14) gave 13 (263 mg, 63%) and 38 (13 mg, 2%).
(1R ,3S ,4S ,5S ,7R ,9R ,10R ,11R )-1,9-Dia ce t yloxy-7-h y-
d r oxylon gip in a n e (13): colorless oil; [R]589 +8°, [R]578 +9°,
[R]546 +10°, [R]436 +19°, [R]365 +35° (c 0.35, CHCl3); IR (CHCl3)
νmax 3612, 3480 (OH), 1728 (CdO acetate), 1254 (C-O) cm-1
;
1H NMR (CDCl3, 300 MHz), see Table 1 and δ 2.09 (3H, s,
OAc), 2.03 (3H, s, OAc), 1.49 (1H, s, OH); 13C NMR (CDCl3,
75.4 MHz), see Table 4 and δ 170.8, 170.6 (CdO acetates), 21.4,
21.3 (Me-acetates); EIMS m/z 296 [M - (CH2dCdO)]+ (2), 278
(3), 263 (1), 236 (13), 218 (45), 203 (24), 185 (19), 175 (75), 159
(48), 147 (34), 133 (36), 123 (42), 107 (40), 96 (100), 81 (21), 69
(18), 55 (9), 43 (47); HRDCIMS (NH3) m/z 356.2437 (calcd for
(1R ,3S ,4S ,5S ,7R ,9R ,10R ,11R )-1,9-Dih yd r oxy-7-p -n i-
tr oben zoyloxylon gip in a n e (35): amorphous white solid
(CH2Cl2/hexane); mp 192 °C; [R]589 +10°, [R]578 +10°, [R]546
+13°, [R]436 +29°, [R]365 low energy (c 0.16, CHCl3); UV (EtOH)
λmax (log ꢀ) 210 (sh) (3.83), 259 (4.06) nm; IR (CHCl3) νmax 3604,
C
19H30O5 + NH4+, 356.2437).
3434 (OH), 1718 (CdO benzoate), 1608 (CdC aromatic), 1530,
1280 (NO2) cm-1; 1H NMR (CDCl3, 300 MHz), see Table 3 and
δ 8.28 and 8.19 (4H, AA′BB′, H-4′,6′ and H-3′,7′ p-nitroben-
zoate), 2.89 (2H, br s, OH); 13C NMR (CDCl3, 75.4 MHz), see
Table 4 and δ 164.3 (CdO benzoate), 150.5 (C-5′), 136.1
(C-2′), 130.6 (C-3′ and C-7′), 123.5 (C-4′ and C-6′); EIMS m/z
385 [M - (H2O)]+ (2), 373 (2), 284 (4), 257 (6), 236 (17), 218
(24), 203 (39), 175 (48), 150 (56), 137 (100), 120 (67), 109 (71),
95 (57), 81 (34), 69 (55), 57 (27), 43 (49); HRDCIMS (NH3) m/z
421.2346 (calcd for C22H29O6N + NH4+, 421.2339).
(1R,3S,4S,5S,7R,9R,10R,11R)-9-Acetyloxy-1-h yd r oxy-7-
p-n itr oben zoyloxylon gip in -a n e (38): pale yellow oil; [R]589
-13°, [R]578 -13°, [R]546 -14°, [R]436 -22°, [R]365 low energy (c
0.13, CHCl3); UV (EtOH) λmax (log ꢀ) 212 (sh) (3.82), 259 (4.04)
nm; IR (CHCl3) νmax 3606, 3504 (OH), 1732 (CdO acetate and
benzoate), 1608 (CdC aromatic), 1530, 1282 (NO2), 1254 (C-
1
O) cm-1; H NMR (CDCl3, 300 MHz), see Table 3 and δ 8.29
and 8.16 (4H, AA′BB′, H-4′,6′ and H-3′,7′ p-nitrobenzoate), 2.22
(3H, s, OAc), 1.65 (1H, br s, OH); 13C NMR (CDCl3, 75.4 MHz),
see Table 4 and δ 171.4 (CdO acetate), 164.0 (CdO benzoate),
150.5 (C-5′), 136.0 (C-2′), 130.6 (C-3′ and C-7′), 123.6 (C-4′ and
C-6′), 21.3 (Me-acetate); EIMS m/z 446 [M + 1]+ (0.2), 415 (2),
403 (7), 236 (35), 218 (100), 175 (77), 150 (57), 120 (61), 95
(51), 81 (33), 69 (25), 43 (46); HRDCIMS (NH3) m/z 463.2458
(calcd for C24H31O7N + NH4+, 463.2444).
(1R ,3S ,4S ,5S ,7R ,9R ,10R ,11R )-1,7-Dih yd r oxy-9-p -n i-
tr oben zoyloxylon gip in a n e (36): white crystals (EtOAc/
hexane); mp 232-233 °C; [R]589 -7°, [R]578 -7°, [R]546 -8°, [R]436
-12°, [R]365 low energy (c 0.16, CHCl3); UV (EtOH) λmax (log ꢀ)
212 (3.93), 259 (4.24) nm; IR (CHCl3) νmax 3612, 3462 (OH),
1718 (CdO benzoate), 1608 (CdC aromatic), 1530, 1276 (NO2)
cm-1; 1H NMR (CDCl3, 300 MHz), see Table 3 and δ 8.28 and
8.20 (4H, AA′BB′, H-4′,6′ and H-3′,7′ p-nitrobenzoate), 1.82
(1H, br s, OH), 1.54-1.48 (1H, br s, OH); 13C NMR (CDCl3,
75.4 MHz), see Table 4 and δ 164.3 (CdO benzoate), 150.5
(C-5′), 136.0 (C-2′), 130.6 (C-3′ and C-7′), 123.5 (C-4′ and C-6′);
EIMS m/z 385 [M - (H2O)]+ (2), 236 (17), 218 (35), 203 (26),
193 (38), 175 (64), 159 (29), 150 (89), 137 (52), 121 (53), 107
(56), 96 (100), 81 (33), 69 (32), 55 (15), 43 (34); HRDCIMS
(NH3) m/z 421.2350 (calcd for C22H29O6N + NH4+, 421.2339).
(1R,3S,4S,5S,7R,9R,10R,11R)-1,9-Dia cet yloxy-7-p -n i-
tr oben zoyloxylon gip in a n e (37). A solution of 35 (600 mg,
1.5 mmol) in AcCl (3.5 g) was refluxed for 10 min. The AcCl
was removed by distillation, and the residue was extracted
with EtOAc. The organic layer was washed with a saturated
aqueous solution of NaHCO3 and H2O, dried over anhydrous
Na2SO4, filtered, and evaporated under vacuum. The residue
was chromatographed on silica gel using EtOAc/hexane (1:4)
as eluent to give 37 (807 mg, 95%) as a pale yellow oil: [R]589
-22°, [R]578 -22°, [R]546 -25°, [R]436 -38°, [R]365 low energy (c
0.15, CHCl3); UV (EtOH) λmax (log ꢀ) 258 (4.17) nm; IR (CHCl3)
νmax 1732 (CdO acetate), 1718 (CdO benzoate), 1608 (CdC
(1R,3S,4S,5S,7R,9R,10R,11R)-1-Acetyloxy-9-h yd r oxy-7-
p-n itr oben zoyloxylon gip in a n e (39): pale yellow oil; [R]589
-10°, [R]578 -10°, [R]546 -12°, [R]436 -19°, [R]365 low energy (c
0.04, CHCl3); UV (EtOH) λmax (log ꢀ) 212 (sh) (3.80), 259 (3.95)
nm; IR (CHCl3) νmax 3250 (OH), 1720 (CdO acetate and
benzoate), 1608 (CdC aromatic), 1530, 1280 (NO2), 1258
1
(C-O) cm-1; H NMR (CDCl3, 300 MHz), see Table 3 and δ
8.30 and 8.19 (4H, AA′BB′, H-4′,6′ and H-3′,7′ p-nitrobenzoate),
2.05 (3H, s, OAc), 1.60 (1H, br s, OH); 13C NMR (CDCl3, 75.4
MHz), see Table 4 and δ 170.8 (CdO acetate), 164.2 (CdO
benzoate), 150.5 (C-5′), 136.1 (C-2′), 130.6 (C-3′ and C-7′), 123.6
(C-4′ and C-6′), 21.5 (Me-acetate); EIMS m/z 445 [M]+ (0.1),
415 (1), 385 (1), 343 (3), 236 (7), 218 (51), 203 (35), 176 (65),
159 (45), 150 (46), 121 (100), 107 (51), 95 (45), 81 (20), 69 (27),
43 (33); HRDCIMS (NH3) m/z 463.2434 (calcd for C24H31O7N
+ NH4+, 463.2444).
Oxid a tion of 13. Using the procedure described above,
compound 13 (100 mg, 0.3 mmol) in AcOH (1 mL) was treated
with CrO3 (100 mg) to yield 72 mg (72%) of 19 and 13 mg (12%)
of 40.
(1R,3S,4S,5S,9R,10R,11R)-1,9-Dia cetyloxy-7-oxolon gip -
in a n e (19): colorless oil; [R]589 +1°, [R]578 +2°, [R]546 +3°, [R]436
+27°, [R]365 +121° (c 0.16, CHCl3); IR (CHCl3) νmax 1728
aromatic), 1530, 1282 (NO2), 1258 (C-O) cm-1 1H NMR
;
(CDCl3, 300 MHz), see Table 3 and δ 8.28 and 8.16 (4H,
AA′BB′, H-4′,6′ and H-3′,7′ p-nitrobenzoate), 2.17 (3H, s, OAc),
2.06 (3H, s, OAc); 13C NMR (CDCl3, 75.4 MHz), see Table 4
and δ 171.2, 170.6 (CdO acetates), 163.9 (CdO benzoate),
150.5 (C-5′), 136.0 (C-2′), 130.5 (C-3′ and C-7′), 123.5 (C-4′ and
C-6′), 21.4, 21.2 (Me-acetates); EIMS m/z 457 [M - (NO)]+ (11),
445 (14), 385 (6), 367 (7), 278 (7), 268 (14), 218 (55), 200 (46),
120 (100), 95 (16), 43 (14); HRDCIMS (NH3) m/z 505.2569
(calcd for C26H33O8N + NH4+, 505.2550).
(CdO acetate), 1720 (CdO cycloheptanone), 1228 (C-O) cm-1
;
1H NMR (CDCl3, 300 MHz), see Table 1 and δ 2.04 (3H, s,
OAc), 1.99 (3H, s, OAc); 13C NMR (CDCl3, 75.4 MHz), see Table
4 and δ 170.6, 170.5 (CdO acetates), 21.3, 21.0 (Me-acetates);
EIMS m/z 336 [M]+ (0.1), 308 (2), 294 (8), 277 (5), 234 (47),
216 (29), 188 (30), 173 (66), 159 (38), 145 (69), 123 (64), 96
(100), 83 (23), 69 (17), 55 (8), 43 (83); HRDCIMS (NH3) m/z
354.2273 (calcd for C19H28O5 + NH4+, 354.2280).
Alk a lin e Hyd r olysis of 37. A solution of 37 (600 mg, 1.2
mmol) in MeOH (38 mL) was treated with a 1.6 N solution of
KOH (7.5 mL). The reaction mixture was stored at room
temperature for 7 min and then neutralized by addition of
dilute HCl (20%). The MeOH was evaporated, and the residue
was extracted with EtOAc. The organic layer was washed with
H2O, dried over anhydrous Na2SO4, and filtered. The solvent
was evaporated under vacuum, and the residue was flash
chromatographed on silica gel. Fractions that eluted with
EtOAc/hexane (2:3) gave unreacted 37 (30 mg, 5%), 39 (7.5
mg, 1%), a mixture of 13 and 38 (295 mg), and 17 (84.5 mg,
(1R,3R,4S,5S,9R,10R,11R)-1,9-Dia cetyloxy-3-h yd r oxy-
7-oxolon gip in a n e (40): white solid; mp 143-145 °C; [R]589
+12°, [R]578 +16°, [R]546 +16°, [R]436 +36°, [R]365 +104° (c 0.03,
CHCl3); IR (CHCl3) νmax 3674 (OH), 1732 (CdO acetate), 1696
(CdO cycloheptanone), 1244 (C-O) cm-1; 1H NMR (CDCl3, 300
MHz), see Table 3 and δ 2.08 (3H, s, OAc), 2.01 (3H, s, OAc),
1.75 (1H, br s, OH); 13C NMR (CDCl3, 75.4 MHz), see Table 4
and δ 170.6, 170.4 (CdO acetates), 21.3, 21.1 (Me-acetates);
EIMS m/z 352 [M]+ (0.2), 334 (0.3), 310 (2), 292 (3), 274 (3),
250 (8), 232 (36), 214 (28), 189 (55), 171 (59), 161 (55), 147